Q32 Bio Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Q32 Bio Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 708% in 3 years; of every extra $100 of sales, $154 became extra profit. Higher than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$154Sales grew 708% in 3 years; of every extra $100 of sales, $154 became extra profit.
Higher than 86% of Healthcare companies in United States.
Asset Productivity Ratio
+708% / +0%In 3 years sales changed by +708% while total assets changed by +0%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-5.4×Operating cash was negative last year, while some debt falls due within a year.
Higher than 59% of Healthcare companies in United States.
Cash Cushion Ratio
+13%Cash, after subtracting all debt, equals 13% of its market value (net cash).
Higher than 54% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Q32 Bio Inc. owes $0.09 for every $1 it owns. Q32 Bio Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
2.8Investors pay $2.8 for every $1 of Q32 Bio Inc.'s yearly profit, lower than 88% of Healthcare companies in United States.
P/B ratio
2.47The share price is 2.47 times Q32 Bio Inc.'s book value per share, lower than 51% of Healthcare companies in United States.
Market cap
$262 MThe total market value of all of Q32 Bio Inc.'s shares at today's price (share price × number of shares), smaller than 54% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$106 MWhat Q32 Bio Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.56Net worth divided by the number of shares. The share price of $8.80 is 2.5 times this, which is the P/B above.
Return on equity (ROE)
72.1%Q32 Bio Inc. earned 72.1% on its shareholders' money over the last year, higher than 97% of Healthcare companies in United States.
Owes vs Owns
0.09×Q32 Bio Inc. owes $0.09 for every $1 it owns (low), lower than 89% of Healthcare companies in United States.
Dividend yield
NoneQ32 Bio Inc. does not currently pay a dividend.
Profit growth
Back to profitQ32 Bio Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
55.5%Q32 Bio Inc. keeps $55 of every $100 of revenue as net profit.
Cash quality
-1.1×Cash from Q32 Bio Inc.'s business was -1.1× its reported profit in the year to Dec 2025 — the business used cash even though it reported a profit.
Interest cover
15.4×Q32 Bio Inc.'s operating profit covered its interest costs 15.4 times in the year to Dec 2025.
Cash vs debt
Net cashQ32 Bio Inc. held $33 M more cash than debt (net cash) at Dec 2025.
Questions
What is Q32 Bio Inc.'s P/E ratio?
Investors pay $2.8 for every $1 of Q32 Bio Inc.'s yearly profit, lower than 88% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Q32 Bio Inc.: $262 M ÷ $106 M (30 Jun 2026) = 2.5.
What is Q32 Bio Inc.'s return on equity?
Q32 Bio Inc. earned 72.1% on its shareholders' money over the last year, higher than 97% of Healthcare companies in United States.
How much does Q32 Bio Inc. owe compared with what it owns?
Q32 Bio Inc. owes $0.09 for every $1 it owns (low), lower than 89% of Healthcare companies in United States.
Does Q32 Bio Inc. pay a dividend?
No. Q32 Bio Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.